High Dose Chemotherapy Followed By PBSC Rescue for HD

This study is ongoing, but not recruiting participants.

First Received: September 13, 2005 Last Updated: December 4, 2007 History of Changes

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00186251

Purpose

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

Condition	Intervention
Hodgkin Disease	Procedure: high dose chemo then auto hematopoietic cell transplant

MedlinePlus related topics: Hodgkin's Disease

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Official Title:	Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Further study details as provided by Stanford University:

Primary Outcome Measures:

Secondary Outcome Measures:

Estimated Enrollment:	200
Study Start Date:	March 1998
Estimated Study Completion Date:	July 2005

Detailed Description:

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Eligibility

Criteria

Inclusion Criteria:- adequate organ function

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186251

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Sally Arai

Stanford University

More Information

No publications provided

Study ID Numbers:	BMT24, BMT24, NCT00186251
Study First Received:	September 13, 2005
Last Updated:	December 4, 2007
ClinicalTrials.gov Identifier:	NCT00186251 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lymphatic Diseases
Immunoproliferative Disorders
Hodgkin Lymphoma, Adult
Hodgkin's Disease

Lymphoproliferative Disorders
Lymphoma
Hodgkin Disease

Additional relevant MeSH terms:

Lymphatic Diseases
Neoplasms
Immunoproliferative Disorders
Neoplasms by Histologic Type

Immune System Diseases
Lymphoproliferative Disorders
Lymphoma
Hodgkin Disease

ClinicalTrials.gov processed this record on May 07, 2009